< Back to previous page
Researcher
Ben Caljon
- Keywords:Medicine
- Disciplines:Epigenetics, Genetics, Clinical genetics and molecular diagnostics, Microbiome, Transcription and translation, Other basic sciences not elsewhere classified
Affiliations
- Genetics Reproduction and Development (Research group)
Member
From1 Jan 2023 → Today - UZB Other (Department)
Member
From1 Jan 2020 → Today - Clinical sciences (Department)
Member
From12 Mar 2025 → Today - Genetics Reproduction and Development (Research group)
Member
From12 Mar 2025 → Today - Genetics Reproduction and Development (Research group)
Member
From1 Jan 2024 → Today - Clinical sciences (Department)
Member
From15 Dec 2019 → Today - Clinical sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Medical Genetics (Department)
Member
From1 Jan 2014 → 31 Dec 2019 - Department of Embryology and Genetics (Department)
Member
From1 Jun 2010 → 31 Dec 2013
Publications
1 - 10 of 15
- Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma(2024)Published in: Neuro-oncologyISSN: 1522-8517Issue: 12Volume: 26Pages: 2208-2221
- A milder form of NSRP1-associated neurodevelopmental disorder, caused by a missense variant in the nuclear localization signal(2024)Published in: American Journal of Medical GeneticsISSN: 1552-4825Issue: 10Volume: 194
- Micro RNA in Semen/Urine from Non-Obstructive Azoospermia Patients as Biomarkers to Predict the Presence of Testicular Spermatozoa and Spermatogonia(2023)Published in: LifeISSN: 2075-1729Issue: 3Volume: 13
- Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates(2023)Published in: Sci. Rep.ISSN: 2045-2322Issue: 1Volume: 13
- Transcriptomic differences between fibrotic and non-fibrotic testicular tissue reveal possible key players in Klinefelter syndrome-related testicular fibrosis(2022)Published in: Sci. Rep.ISSN: 2045-2322Issue: 1Volume: 12
- Molecular characterization of extraintestinal and diarrheagenic Escherichia coli blood isolates(2022)Published in: VirulenceISSN: 2150-5594Issue: 1Volume: 13Pages: 2032-2041
- Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study(2022)Published in: Cancers (Basel)ISSN: 2072-6694Issue: 19Volume: 14
- Healthcare-Associated COVID-19 across Five Pandemic Waves(2022)Published in: VirusesISSN: 1999-4915Issue: 10Volume: 14
- An exome-wide study of renal operational tolerance(2022)Published in: Frontiers in MedicineISSN: 2296-858XVolume: 9
- Detection of Heteroplasmic Variants in the Mitochondrial Genome through Massive Parallel Sequencing(2019)Published in: bio-protocolISSN: 2331-8325Issue: 13Volume: 9
Linked dataset
1 - 7 of 7
- Additional file 6: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
- Additional file 1: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
- Additional file 3: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
- Additional file 11: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
- Additional file 9: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
- Additional file 8: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
- Additional file 4: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families